期刊文献+

腺苷三磷酸肿瘤药敏试验在妇科肿瘤中的应用研究进展

Progress of ATP tumor chemoseusitivity assay in gynecologic cancer
下载PDF
导出
摘要 由于肿瘤存在异质性及耐药性,选择敏感药物实施个体化治疗可望改善妇科肿瘤患者的预后。体外化疗药物敏感试验是目前肿瘤领域的一大研究热点。腺苷三磷酸肿瘤药物敏感试验(ATP TCA)是目前可评价率较高、检测结果与临床相关性较好的体外药敏试验方法;现综述其在妇科肿瘤领域的研究进展。
出处 《国外医学(肿瘤学分册)》 2005年第3期215-218,共4页 Foreign Medical Sciences (Cancer Section)
  • 相关文献

参考文献18

  • 1Konecny G, Crohns C, Pegram M, et al. Correlation of drug response with the ATP tumor-chemosensitivity assay in primary FIGO stage Ⅲovarian cancer. Gynecol Oncol,2000,77 (2) :258-263.
  • 2O' Meara AT, Sevin BU. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer. Gynecol Oncol,2001,83 (2) :334-342.
  • 3Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin,2004,54(1) :8-29.
  • 4Di Nicolantonio F,Neale MH,Knight LA,et al. Use of an ATP-based chemosensitivity assay to design new combinations of high-concentration doxorubicin with other drugs for recurrent ovarian cancer. Anticancer Drugs,2002,13 (6): 625- 630.
  • 5Kurbacher CM,Cree IA,Bruckner HW,et al. Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer. Anticancer Drugs, 1998,9(1) :51-57.
  • 6Ng TY, Ngan HY, Cheng DK, et al. Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples.Gynecol Oncol,2000,76 (3) :405-408.
  • 7Sharma S,Neale MH,Di Nicolantonio F,et al. Outcome of ATP- based tumor chemosensitivity assay directed chemotherapy in heavily pretreated recurrent ovarian carcinoma. BMC Cancer,2003,3 (1) :19.
  • 8Breidenbach M, Rein DT, Schondorf T, et al. Hematological sideeffect profiles of individualized chemotherapy regimen for recurrent ovarian cancer. Anticancer Drugs ,2003,14 (5) :341-346.
  • 9O'meara AT,Sevin BU. In vitro sensitivity of fresh ovarian carcinoma specimens to CPT- 11 ( irinotecan). Gynecol Oncol, 1999,72 (2): 143-147.
  • 10Neale MH,Charlton PA,Cree IA. Ex vivo activity of XR5000 against solid tumors. Anticancer Drugs,2000,11 (6) :471-478.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部